Stay updated on Organon & Co. Press Releases
Sign up to get notified when there's something new on the Organon & Co. Press Releases page.

Latest updates to the Organon & Co. Press Releases page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes the FDA's approval of Henlius and Organon's biosimilars BILDYOS® and BILPREVDA®, while the previous mention of Organon's acquisition of TOFIDENCE™ has been removed.SummaryDifference13%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe web page has updated its reporting date to August 5, 2025, reflecting the latest results for Organon, while removing a previous announcement regarding the EMA's validation of a biosimilar candidate.SummaryDifference8%
- Check47 days agoChange DetectedThe Consumer Health Data Policy has been removed from the web page.SummaryDifference1.0%
- Check54 days agoChange DetectedThe webpage has updated its news section with new announcements regarding Organon's products and corporate activities, including a strong recommendation for VTAMA® in dermatology guidelines and the appointment of a new board member. Additionally, the total number of news items has been adjusted.SummaryDifference14%
- Check68 days agoChange DetectedThe page now includes a significant update regarding Organon’s VTAMA® cream, which has received a strong recommendation in the updated guidelines for adult atopic dermatitis. Additionally, the total number of items listed has increased from 120 to 121.SummaryDifference10%
- Check75 days agoChange DetectedThe page has been updated to include a new announcement regarding Organon's Phase 2 ELENA study for OG-6219, while a previous announcement about the fourth quarter and full year 2024 results has been removed.SummaryDifference10%
Stay in the know with updates to Organon & Co. Press Releases
Enter your email address, and we'll notify you when there's something new on the Organon & Co. Press Releases page.